Disclosed are humanized antibodies that bind specifically to TNF superfamily member 15 (TNFSF 15), also known as TL1A. Methods of making and using the anti-TL1 A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.
申请公布号
UA104132(C2)
申请公布日期
2014.01.10
申请号
UA20100007142
申请日期
2008.11.13
申请人
TEVA BIOPHARMACEUTICALS USA, INC.
发明人
SMITH, RODGER;KANAKARAJ, PALANISAMY;ROSCHKE, VIKTOR;ROSEN, CRAIG;COOKSEY, BRIDGET, A.